Publications by authors named "D Chirio"

Claim this Profile
U
Use of mogamulizumab in cutaneous T-cell lymphomas among people living with HIV: insights from a nationwide French cohort.
Laura Troin, Henri Adamski, Perrine Rousset, Florence Poizeau, David Chirio

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation and Comparative Characterization of SLNs and NLCs for Targeted Co-Delivery of Paclitaxel and Hydroxytyrosol Carboxylic Acid Esters Against Triple-Negative Breast Cancer.
Elena Peira, Simona Sapino, Daniela Chirio, Fabio Bucciol, Flavia Turku

Pharmaceutics· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To Switch or not to Switch to Long-acting Injectable Cabotegravir/Rilpivirine in PWH With Past Hepatitis B Virus (HBV) Coinfection: Which HBV Markers to Manage Risk of HBV Reactivation?
Laurence Ollier, Anne De Monte, Vincent Thibault, Pascal Pugliese, David Chirio

Open Forum Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosenescence markers in T- and NK-cells according to the CD4/CD8 ratio in successfully treated people living with HIV.
Matteo Vassallo, Jacques Durant, Sami Addou, Michel Ticchioni, Roxane Fabre, David Chirio

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel bevacizumab delivery system using solid lipid nanoparticles for potential wet age-related macular degeneration treatment: An in vivo study.
Ángel Parra-Sánchez, Gema Martínez-Navarrete, Giulia Accomasso, Giulia Chindamo, Daniela Chirio

Int J Pharm· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis